CBSET
Peter Markham is a seasoned executive with extensive experience in the life sciences and pharmaceuticals sectors. Since June 2006, Peter has served as President and CEO of CBSET. Prior to this role, Peter worked as a consultant at MIT from 2004 to 2006 and held the position of General Manager at Charles River Laboratories from 2001 to 2004. Additionally, Peter was the General Manager at Charles River Laboratories (formerly Primedica) during the same period. Earlier in the career, Peter was the Director of Metabolism at GTC Mason Laboratories from 1995 to 2001 and spent a decade at Arthur D. Little as an AD Drug Metabolism/PK specialist from 1985 to 1995. Peter holds a degree from the University of Massachusetts Amherst.
This person is not in any teams
This person is not in any offices
CBSET
CBSET Inc. is a state-of-the-art preclinical translational research institute dedicated to the advancement of early-stage biomedical technologies. CBSET’s mission is to help our sponsors develop unique tools and novel methods to promote early diagnosis and develop innovative treatments for complex diseases. CBSET specializes in the development and application of novel minimally invasive techniques in the fields of cardiology, endoscopy, surgery, drug and device delivery, drug and device safety, and diagnostic imaging.